Full Breakdown
Fiji Declares HIV Emergency Amid Meth-Driven Surge
By Drooid · · How we work
Emergency Declaration and Immediate Response
In mid-September 2026 the Fijian government announced a national health emergency after a rapid rise in HIV infections. Mobile clinics, such as the one run by Dr Kesaia Tuidraki’s team outside a downtown Suva fast-food outlet, began rapid testing of youths; of the 97 people screened, roughly one in six tested positive. The emergency will enable expanded powers for testing, treatment and harm-reduction measures, including a pending amendment to the HIV Act that would permit public-health workers to distribute sterile needles.
Background: Rising Infections and Methamphetamine Use
Fiji’s HIV epidemic has expanded twelve-fold since 2010, with an estimated 9,000-9,100 people living with the virus in a population of about 930,000. New diagnoses in 2025 rose 27 % to 2,016 cases. The surge is linked to a crystal-methamphetamine epidemic; the drug’s domestic market grew after COVID-19 border closures, leading many young people—some as young as nine—to inject meth. Shared-needle practices, including “bluetoothing,” have become common in impoverished communities.
Data and Statistics
- Prevalence: ~1.7 % of adults (?1 in 60).
- Diagnosed cases: 5,676 officially recorded; only about 39 % know their status.
- Age distribution: Two-thirds of new cases are in people aged 20-34.
- Transmission (2025): 42 % linked to contaminated needles, 50 % to sexual intercourse.
- Maternal impact: 2 % of pregnant women are HIV-positive; 59 infants were born with HIV in 2025.
- Funding: The response will cost an additional 23 million FJD (?US$10.2 million) annually, supplemented by A$48 million from Australia and NZ$4.2 million from New Zealand.
Official Statements & Responses
Dr Jason Mitchell, head of Fiji’s HIV response, warned that without rapid interventions the epidemic could continue to grow for years. UNAids regional director Eamonn Murphy called the needle-and-syringe programme “essential to curbing transmission.” Australian and New Zealand officials pledged multi-million-dollar aid for testing, treatment and preventive supplies.
Criticism & Opposition
Some politicians and medical professionals argue that legalising needle distribution could encourage drug use, despite UNAids evidence to the contrary. Current law classifies the provision of syringes as “aiding and abetting” drug use, creating tension between public-health goals and law-enforcement policies.
On-the-Ground Reports
HIV activist Mark Lal recounts losing two close friends to the disease and notes community blame directed at marginalized groups.
Conflicting Reports & Gaps
Sources differ on the total number of people living with HIV, citing roughly 9,100 (Guardian) and “upward of 9,000” with some estimates as high as 12,000. Diagnosed cases are reported as 5,676 versus a broader estimate of 9,100 living with the virus, indicating a gap in testing coverage and data consolidation.
Verbatim Quotes
- “It’s really sad, honestly. We can’t wait any more, there are boxes and boxes already here,” — Tuidraki, country director of Medical Services Pacific.
- “The immediate crisis right now is the spread of HIV, which is why the needle and syringe programme is critical,” — Eamonn Murphy, UNAids regional director.
- “Time is not on our side," says Soqo.” — Sailosi Soqo, doctor on the national HIV response team.
What’s Next
Legislative changes to the HIV Act are expected within two weeks, enabling needle distribution. The response team plans to hire at least 100 additional staff, open new clinics and integrate HIV services into general practice. Pilot programmes for long-acting injectable PrEP (lenacapavir) and vaginal rings are slated for rollout, while projections suggest the infected population could reach 25,000 by 2029 if current trends persist.